Influence of the legislation on the advertisement of psychoactive medications in Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2003 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1590/S1516-44462003000300006 http://repositorio.unifesp.br/handle/11600/1840 |
Resumo: | OBJECTIVE: The regulations on the advertisement of medications aim to encourage and promote an improved health care and the rational use of medications. The objective of this paper is to evaluate the influence of three regulations on the advertisement of medications: the Export act, published in the United States in 1986; the WHO's Criteria, published in 1988, and the Resolution 102/2000 of the Collegiate Board of Directors of the ANVISA (Agência Nacional de Vigilância Sanitária- Brazilian Sanitary Surveillance Agency), on the advertisement of psychoactive medications. METHOD: We collected advertisements that were published in Brazilian psychiatric journals before and after the regulations were established. The contents of the advertisements were analyzed according to a program created based on the regulation's demands. RESULTS: In the 118 analyzed issues there were 199 different advertisements on 85 psychotropic drugs. We observed that, regardless the studied medication, the information about restrictions of use, such as adverse drug reactions, interactions, contraindications, warnings and precautions, does not appear very often, and when it does, its print sizes were smaller than that of the information favoring the use, such as indication, presentation and dosage. After the publication of the regulations, only 38.2% of the advertisements had all the essential technical information, and 35.3% were irregular in some way. CONCLUSION: The data suggest that there was very little influence of the regulations on the advertisement of psychotropic drugs in Brazil. Consequently, other control measures are necessary in addition to the regulations. |
id |
UFSP_ce8013ad00ff21c3c3463e360cdd9591 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/1840 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Influence of the legislation on the advertisement of psychoactive medications in BrazilInfluência da legislação sobre as propagandas de medicamentos psicoativos no BrasilAdvertisingLegislation about drugLegislation on medicationPsychotropic drugsPublicidadeLeis sobre medicamentosLegislaçãoPublicidade de medicamentosPsicotrópicosOBJECTIVE: The regulations on the advertisement of medications aim to encourage and promote an improved health care and the rational use of medications. The objective of this paper is to evaluate the influence of three regulations on the advertisement of medications: the Export act, published in the United States in 1986; the WHO's Criteria, published in 1988, and the Resolution 102/2000 of the Collegiate Board of Directors of the ANVISA (Agência Nacional de Vigilância Sanitária- Brazilian Sanitary Surveillance Agency), on the advertisement of psychoactive medications. METHOD: We collected advertisements that were published in Brazilian psychiatric journals before and after the regulations were established. The contents of the advertisements were analyzed according to a program created based on the regulation's demands. RESULTS: In the 118 analyzed issues there were 199 different advertisements on 85 psychotropic drugs. We observed that, regardless the studied medication, the information about restrictions of use, such as adverse drug reactions, interactions, contraindications, warnings and precautions, does not appear very often, and when it does, its print sizes were smaller than that of the information favoring the use, such as indication, presentation and dosage. After the publication of the regulations, only 38.2% of the advertisements had all the essential technical information, and 35.3% were irregular in some way. CONCLUSION: The data suggest that there was very little influence of the regulations on the advertisement of psychotropic drugs in Brazil. Consequently, other control measures are necessary in addition to the regulations.OBJETIVO: Os regulamentos sobre propaganda de medicamentos visam apoiar e fomentar a melhoria da atenção à saúde e o uso racional de medicamentos. O objetivo deste trabalho é avaliar a influência de três regulamentos sobre propaganda de medicamentos: Export act, publicado em 1986 nos Estados Unidos; os Critérios da OMS, em 1988 e a Resolução da Diretoria Colegiada n° 102 de 2000 da ANVISA (Agência Nacional de Vigilância Sanitária), sobre os anúncios de medicamentos psicoativos. MÉTODO: Foram coletados anúncios em periódicos de psiquiatria nacionais, publicados antes e após cada regulamento. O conteúdo dos anúncios foi analisado de acordo com um roteiro de análise de conteúdo elaborado segundo as exigências dos regulamentos. RESULTADOS: Dos 118 fascículos analisados, foram obtidos 199 anúncios diferentes de 85 medicamentos psicoativos. Observou-se que, independentemente do regulamento estudado, as informações que restringem o uso, como reações adversas ao medicamento (RAM), interações, contra-indicações, advertências e precauções estão presentes em menor freqüência e num tamanho de letra menor do que as informações que favorecem o uso, como indicação, apresentação e posologia. Depois de todos os atos publicados apenas 38,2% dos anúncios continham todas as informações técnicas imprescindíveis, e 35,3% dos anúncios apresentavam alguma irregularidade. CONCLUSÃO: Os dados sugerem que houve pouca influência dos regulamentos sobre os anúncios de medicamentos psicoativos no Brasil, portanto, faz-se necessário adotar outras medidas de controle além de regulamentos.Federal University of São Paulo Paulista Medical School Department of PsychobiologyUniversity of São Paulo Paulista Medical School Department of PsychobiologyUNIFESP, EPM, Department of PsychobiologySciELOAssociação Brasileira de Psiquiatria - ABPUniversidade Federal de São Paulo (UNIFESP)University of São Paulo Paulista Medical School Department of PsychobiologyMastroianni, Patrícia de Carvalho [UNIFESP]Galduróz, José Carlos Fernandes [UNIFESP]Carlini, Elisaldo Araujo [UNIFESP]2015-06-14T13:30:07Z2015-06-14T13:30:07Z2003-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion146-155application/pdfhttp://dx.doi.org/10.1590/S1516-44462003000300006Revista Brasileira de Psiquiatria. Associação Brasileira de Psiquiatria - ABP, v. 25, n. 3, p. 146-155, 2003.10.1590/S1516-44462003000300006S1516-44462003000300006.pdf1516-4446S1516-44462003000300006http://repositorio.unifesp.br/handle/11600/1840engRevista Brasileira de Psiquiatriainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-30T01:19:19Zoai:repositorio.unifesp.br/:11600/1840Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-07-30T01:19:19Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Influence of the legislation on the advertisement of psychoactive medications in Brazil Influência da legislação sobre as propagandas de medicamentos psicoativos no Brasil |
title |
Influence of the legislation on the advertisement of psychoactive medications in Brazil |
spellingShingle |
Influence of the legislation on the advertisement of psychoactive medications in Brazil Mastroianni, Patrícia de Carvalho [UNIFESP] Advertising Legislation about drug Legislation on medication Psychotropic drugs Publicidade Leis sobre medicamentos Legislação Publicidade de medicamentos Psicotrópicos |
title_short |
Influence of the legislation on the advertisement of psychoactive medications in Brazil |
title_full |
Influence of the legislation on the advertisement of psychoactive medications in Brazil |
title_fullStr |
Influence of the legislation on the advertisement of psychoactive medications in Brazil |
title_full_unstemmed |
Influence of the legislation on the advertisement of psychoactive medications in Brazil |
title_sort |
Influence of the legislation on the advertisement of psychoactive medications in Brazil |
author |
Mastroianni, Patrícia de Carvalho [UNIFESP] |
author_facet |
Mastroianni, Patrícia de Carvalho [UNIFESP] Galduróz, José Carlos Fernandes [UNIFESP] Carlini, Elisaldo Araujo [UNIFESP] |
author_role |
author |
author2 |
Galduróz, José Carlos Fernandes [UNIFESP] Carlini, Elisaldo Araujo [UNIFESP] |
author2_role |
author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) University of São Paulo Paulista Medical School Department of Psychobiology |
dc.contributor.author.fl_str_mv |
Mastroianni, Patrícia de Carvalho [UNIFESP] Galduróz, José Carlos Fernandes [UNIFESP] Carlini, Elisaldo Araujo [UNIFESP] |
dc.subject.por.fl_str_mv |
Advertising Legislation about drug Legislation on medication Psychotropic drugs Publicidade Leis sobre medicamentos Legislação Publicidade de medicamentos Psicotrópicos |
topic |
Advertising Legislation about drug Legislation on medication Psychotropic drugs Publicidade Leis sobre medicamentos Legislação Publicidade de medicamentos Psicotrópicos |
description |
OBJECTIVE: The regulations on the advertisement of medications aim to encourage and promote an improved health care and the rational use of medications. The objective of this paper is to evaluate the influence of three regulations on the advertisement of medications: the Export act, published in the United States in 1986; the WHO's Criteria, published in 1988, and the Resolution 102/2000 of the Collegiate Board of Directors of the ANVISA (Agência Nacional de Vigilância Sanitária- Brazilian Sanitary Surveillance Agency), on the advertisement of psychoactive medications. METHOD: We collected advertisements that were published in Brazilian psychiatric journals before and after the regulations were established. The contents of the advertisements were analyzed according to a program created based on the regulation's demands. RESULTS: In the 118 analyzed issues there were 199 different advertisements on 85 psychotropic drugs. We observed that, regardless the studied medication, the information about restrictions of use, such as adverse drug reactions, interactions, contraindications, warnings and precautions, does not appear very often, and when it does, its print sizes were smaller than that of the information favoring the use, such as indication, presentation and dosage. After the publication of the regulations, only 38.2% of the advertisements had all the essential technical information, and 35.3% were irregular in some way. CONCLUSION: The data suggest that there was very little influence of the regulations on the advertisement of psychotropic drugs in Brazil. Consequently, other control measures are necessary in addition to the regulations. |
publishDate |
2003 |
dc.date.none.fl_str_mv |
2003-09-01 2015-06-14T13:30:07Z 2015-06-14T13:30:07Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S1516-44462003000300006 Revista Brasileira de Psiquiatria. Associação Brasileira de Psiquiatria - ABP, v. 25, n. 3, p. 146-155, 2003. 10.1590/S1516-44462003000300006 S1516-44462003000300006.pdf 1516-4446 S1516-44462003000300006 http://repositorio.unifesp.br/handle/11600/1840 |
url |
http://dx.doi.org/10.1590/S1516-44462003000300006 http://repositorio.unifesp.br/handle/11600/1840 |
identifier_str_mv |
Revista Brasileira de Psiquiatria. Associação Brasileira de Psiquiatria - ABP, v. 25, n. 3, p. 146-155, 2003. 10.1590/S1516-44462003000300006 S1516-44462003000300006.pdf 1516-4446 S1516-44462003000300006 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Revista Brasileira de Psiquiatria |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
146-155 application/pdf |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Psiquiatria - ABP |
publisher.none.fl_str_mv |
Associação Brasileira de Psiquiatria - ABP |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268435653197824 |